Results 101 to 110 of about 455,043 (294)

Two-stage public-private partnership proposal for R&D on neglected diseases [PDF]

open access: yes
We propose a 2-stage procurement model of public-private partnership to provide better incentives for R&D on neglected diseases. The model combines advance market commitment, subsidized clinical trials, and rewards based on therapeutical contributions of
Brigitte Granville, Eshref Trushin
core  

Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases [PDF]

open access: yes, 2017
Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point.
Foray, D.   +3 more
core  

A Review on Catalytic Nanostructured Electrodes for Wearable and Implantable Abiotic Glucose Fuel Cells

open access: yesAdvanced Science, EarlyView.
This review identifies current and future directions in abiotic nanostructured catalysts to develop reliable and sustainable glucose fuel cells to power the next generation of bioelectronic devices. ABSTRACT The global rise in incidence of chronic diseases has led to the demand for innovative solutions that help patients manage their conditions with ...
Asghar Niyazi   +3 more
wiley   +1 more source

Correction: Buruli Ulcer in Cameroon: The Development and Impact of the National Control Programme. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2016
PLOS Neglected Tropical Diseases Staff
doaj   +1 more source

Global Diseases, Global Patents and Differential Treatment in WTO Law [PDF]

open access: yes
As of January 1, 2005, all developing country members of the WTO are required to implement the WTO Agreement on Trade Related Intellectual Property Rights (TRIPS). We analyze the issue of access to patented medicine to treat global and neglected diseases
Bradly J Condon, Tapen Sinha
core  

Integrating Spatial Proteogenomics in Cancer Research

open access: yesAdvanced Science, EarlyView.
Xx xx. ABSTRACT Background: Spatial proteogenomics marks a paradigm shift in oncology by integrating molecular analysis with spatial information from both spatial proteomics and other data modalities (e.g., spatial transcriptomics), thereby unveiling tumor heterogeneity and dynamic changes in the microenvironment.
Yida Wang   +13 more
wiley   +1 more source

Correction: Pyrethroid Treatment of Cattle for Tsetse Control: Reducing Its Impact on Dung Fauna. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2015
PLOS Neglected Tropical Diseases Staff
doaj   +1 more source

Editorial: Ethnopharmacological Strategies for Drug Discovery Against African Neglected Diseases. [PDF]

open access: yesFront Pharmacol, 2022
Igoli JO   +4 more
europepmc   +1 more source

Large Scale In Silico Screening on Grid Infrastructures [PDF]

open access: yes, 2006
Large-scale grid infrastructures for in silico drug discovery open opportunities of particular interest to neglected and emerging diseases. In 2005 and 2006, we have been able to deploy large scale in silico docking within the framework of the WISDOM ...
Breton, V.   +19 more
core   +2 more sources

Home - About - Disclaimer - Privacy